281 related articles for article (PubMed ID: 20698697)
21. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
[TBL] [Abstract][Full Text] [Related]
22. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
23. Inequivalent contribution of the five tryptophan residues in the C-lobe of human serum transferrin to the fluorescence increase when iron is released.
James NG; Byrne SL; Steere AN; Smith VC; MacGillivray RT; Mason AB
Biochemistry; 2009 Apr; 48(13):2858-67. PubMed ID: 19281173
[TBL] [Abstract][Full Text] [Related]
24. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
[TBL] [Abstract][Full Text] [Related]
25. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
Yang X; Koh CG; Liu S; Pan X; Santhanam R; Yu B; Peng Y; Pang J; Golan S; Talmon Y; Jin Y; Muthusamy N; Byrd JC; Chan KK; Lee LJ; Marcucci G; Lee RJ
Mol Pharm; 2009; 6(1):221-30. PubMed ID: 19183107
[TBL] [Abstract][Full Text] [Related]
26. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
[TBL] [Abstract][Full Text] [Related]
27. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
28. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
29. Gallium-induced cell death in lymphoma: role of transferrin receptor cycling, involvement of Bax and the mitochondria, and effects of proteasome inhibition.
Chitambar CR; Wereley JP; Matsuyama S
Mol Cancer Ther; 2006 Nov; 5(11):2834-43. PubMed ID: 17121930
[TBL] [Abstract][Full Text] [Related]
30. Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor.
Weissman AM; Klausner RD; Rao K; Harford JB
J Cell Biol; 1986 Mar; 102(3):951-8. PubMed ID: 3005341
[TBL] [Abstract][Full Text] [Related]
31. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
32. The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
Daniels TR; Bernabeu E; Rodríguez JA; Patel S; Kozman M; Chiappetta DA; Holler E; Ljubimova JY; Helguera G; Penichet ML
Biochim Biophys Acta; 2012 Mar; 1820(3):291-317. PubMed ID: 21851850
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
34. In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.
Wängler C; Nada D; Höfner G; Maschauer S; Wängler B; Schneider S; Schirrmacher E; Wanner KT; Schirrmacher R; Prante O
Mol Imaging Biol; 2011 Apr; 13(2):332-41. PubMed ID: 20473573
[TBL] [Abstract][Full Text] [Related]
35. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
36. Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery.
Singh RP; Sharma G; Sonali ; Agrawal P; Pandey BL; Koch B; Muthu MS
Int J Biol Macromol; 2016 Feb; 83():335-44. PubMed ID: 26657586
[TBL] [Abstract][Full Text] [Related]
37. Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles.
Lin R; Li Y; MacDonald T; Wu H; Provenzale J; Peng X; Huang J; Wang L; Wang AY; Yang J; Mao H
Colloids Surf B Biointerfaces; 2017 Feb; 150():261-270. PubMed ID: 28029547
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
Bartlett DW; Davis ME
Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of C-lobe ligands of human serum transferrin: insights into the mechanism of iron release.
Mason AB; Halbrooks PJ; James NG; Connolly SA; Larouche JR; Smith VC; MacGillivray RT; Chasteen ND
Biochemistry; 2005 Jun; 44(22):8013-21. PubMed ID: 15924420
[TBL] [Abstract][Full Text] [Related]
40. Bionano interactions of mcf-7 breast tumor cells with a transferrin receptor targeted nanoparticle.
Du W; Fan Y; He B; Zheng N; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Mol Pharm; 2015 May; 12(5):1467-76. PubMed ID: 25811613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
